Ufp Technologies (UFPT) Non-Current Deferred Tax Liability (2010 - 2026)
Ufp Technologies (UFPT) posted Non-Current Deferred Tax Liability of $11.7 million for Q1 2026, up 27.48% on a QoQ basis from $9.2 million in Q4 2025, and up 138.8% year-over-year from $4.9 million in Q1 2025.
Ufp Technologies (UFPT) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Ufp Technologies' Non-Current Deferred Tax Liability history runs 17 years deep, the most recent figure standing at $11.7 million for Q1 2026.
- Quarterly Non-Current Deferred Tax Liability rose 138.8% year-over-year to $11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 138.8% YoY) and the FY2025 annual result came in at $9.2 million, down 38.36% from the prior year.
- Non-Current Deferred Tax Liability was $11.7 million for Q1 2026 at Ufp Technologies, up from $9.2 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $14.9 million in Q4 2024 and bottomed at $182000.0 in Q2 2024.
- A 5-year average of $4.4 million and a median of $3.4 million in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability plunged 89.27% — and 2024, when it soared 3391.36%.
- Ufp Technologies' Non-Current Deferred Tax Liability stood at $448000.0 in 2022, then declined by 4.46% to $428000.0 in 2023, then surged by 3391.36% to $14.9 million in 2024, then plunged by 38.36% to $9.2 million in 2025, then rose by 27.48% to $11.7 million in 2026.
- Business Quant data shows UFPT's Non-Current Deferred Tax Liability at $11.7 million in Q1 2026, $9.2 million in Q4 2025, and $7.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.74 Mn |
| Mar 31, 2026 | 11.74 Mn |
| Dec 31, 2025 | 9.21 Mn |
| Dec 31, 2025 | 9.21 Mn |
| Sep 30, 2025 | 7.57 Mn |
| Sep 30, 2025 | 7.57 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 4.92 Mn |
| Mar 31, 2025 | 4.92 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Dec 31, 2024 | 14.94 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 575,000.00 |
| Mar 31, 2024 | 575,000.00 |
| Dec 31, 2023 | 428,000.00 |
| Dec 31, 2023 | 428,000.00 |